WANBURY
Back to Balance Sheet
|
WANBURY Last 5 Year Contingent Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Contingent Liabilities | ₹65 Cr | ₹60 Cr | ₹1,072 Cr | ₹934 Cr | ₹889 Cr |
What is the latest Contingent Liabilities ratio of WANBURY ?
| Year | Contingent Liabilities |
|---|---|
| Mar2025 | ₹65 Cr |
| Mar2024 | ₹60 Cr |
| Mar2023 | ₹1,072 Cr |
| Mar2022 | ₹934 Cr |
| Mar2021 | ₹889 Cr |
How is Contingent Liabilities of WANBURY Trending?
| Years | Contingent Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹65 Cr | 9.00 | |
| Mar2024 | ₹60 Cr | -94.43 | |
| Mar2023 | ₹1,072 Cr | 14.78 | |
| Mar2022 | ₹934 Cr | 5.01 | |
| Mar2021 | ₹889 Cr | - | |
Compare Contingent Liabilities of peers of WANBURY
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| WANBURY | ₹897.8 Cr | 10.5% | 4% | 14.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹411,822.0 Cr | 1.6% | 8.2% | -8.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹172,811.0 Cr | -0.8% | 14.4% | 12.2% | Stock Analytics | |
| CIPLA | ₹127,688.0 Cr | -3.9% | 5.5% | 5.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹121,840.0 Cr | -0.5% | 1% | 7.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹104,544.0 Cr | -2.1% | -0% | -2% | Stock Analytics | |
WANBURY Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| WANBURY | 10.5% |
4% |
14.8% |
| SENSEX | 0.7% |
4.7% |
6.1% |
You may also like the below Video Courses